Technology and products provide much-needed solutions to medical needs in animal health, including reducing antibiotic use.
Verovaccines’ current product pipeline includes a number of vaccine projects, several of which have blockbuster potential.
The pipeline of vaccine candidates documents the broad applicability of the proprietary K. lactis technology:
Targeting 6 different pathogens and providing protection in the respective target animals = 6x proof of concept